---
figid: PMC7314471__LIO2-5-360-g001
figtitle: Pathogenesis of aspirin‐exacerbated respiratory disease (AERD)
organisms:
- NA
pmcid: PMC7314471
filename: LIO2-5-360-g001.jpg
figlink: pmc/articles/PMC7314471/figure/lio2387-fig-0001/
number: F1
caption: Pathogenesis of aspirin‐exacerbated respiratory disease (AERD). In normal
  patients, arachidonic acid is broken down into cyclooxygenase (COX)‐1 and COX‐2,
  which are inhibited by nonsteroidal anti‐inflammatory drugs (NSAIDS). However in
  AERD patients, this pathway is shunted towards the 5‐lipoxygenase (5‐LO) pathway,
  causing an increase in production of inflammatory CysLTs
papertitle: 'Aspirin‐exacerbated respiratory disease: A review.'
reftext: Christine Dominas, et al. Laryngoscope Investig Otolaryngol. 2020 Jun;5(3):360-367.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.728416
figid_alias: PMC7314471__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC7314471__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7314471__LIO2-5-360-g001.html
  '@type': Dataset
  description: Pathogenesis of aspirin‐exacerbated respiratory disease (AERD). In
    normal patients, arachidonic acid is broken down into cyclooxygenase (COX)‐1 and
    COX‐2, which are inhibited by nonsteroidal anti‐inflammatory drugs (NSAIDS). However
    in AERD patients, this pathway is shunted towards the 5‐lipoxygenase (5‐LO) pathway,
    causing an increase in production of inflammatory CysLTs
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX4
  - COX5A
  - cid
  - ci
  - lt
  - Rab32
  - COX1
  - COX2
  - Arachidonic
  - PGE2
---
